Extract from the Register of European Patents

EP About this file: EP1663111

EP1663111 - DELIVERY OF PHYSIOLOGIXAL AGENTS WITH IN-SITU GELS COMPRISING ANIONIC POLYSACCHARIDES [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  21.10.2011
Database last updated on 28.03.2026
Most recent event   Tooltip21.10.2011Application deemed to be withdrawnpublished on 23.11.2011  [2011/47]
Applicant(s)For all designated states
Nanotherapeutics, Inc.
13859 Progress Blvd. Suite 300
Alachua, FL 32615 / US
[2010/47]
Former [2009/01]For all designated states
CARRINGTON LABORATORIES, INC.
2001 Walnut Hill Lane
Irving, TX 75038 / US
Former [2006/23]For all designated states
Delsite Biotechnologies, Inc.
1505 Walnut Hill Lane
Irving, TX 75038 / US
Inventor(s)01 / NI, Yawei
702 Aster Drive
College Station, TX 77845 / US
02 / YATES, Kenneth, M.
1412 Crimson Glory Court
Keller, TX 76248 / US
 [2006/23]
Representative(s)Gardner, Rebecca Katherine
Dehns
St Bride's House
10 Salisbury Square
London EC4Y 8JD / GB
[N/P]
Former [2008/33]Gardner, Rebecca Katherine
Frank B. Dehn & Co. St Bride's House 10 Salisbury Square
London EC4Y 8JD / GB
Former [2006/23]Gardner, Rebecca Katherine
Frank B. Dehn & Co. St Bride's House 10 Salisbury Square
London EC4Y 8JD / GB
Application number, filing date04753044.924.05.2004
[2006/23]
WO2004US16146
Priority number, dateUS2003065262229.08.2003         Original published format: US 652622
[2006/23]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2005023176
Date:17.03.2005
Language:EN
[2005/11]
Type: A2 Application without search report 
No.:EP1663111
Date:07.06.2006
Language:EN
The application published by WIPO in one of the EPO official languages on 17.03.2005 takes the place of the publication of the European patent application.
[2006/23]
Search report(s)International search report - published on:US15.06.2006
(Supplementary) European search report - dispatched on:EP16.09.2009
ClassificationIPC:A61K9/06, A61K47/36, A61K38/18, A61K39/39
[2009/42]
CPC:
A61K9/0024 (EP,US); A61K9/20 (KR); A61K38/1825 (EP,US);
A61K39/05 (EP,US); A61K39/12 (EP,US); A61K39/39 (EP,US);
A61K47/36 (EP,KR,US); A61K9/06 (EP,US); A61K9/48 (KR);
A61P17/02 (EP); A61P31/16 (EP); A61P37/04 (EP);
A61K2039/5252 (EP,US); A61K2039/543 (EP,US); A61K2039/55505 (EP,US);
A61K2039/55583 (EP,US); A61K2039/70 (EP,US); B82Y5/00 (KR);
C12N2760/16134 (EP,US) (-)
Former IPC [2006/23]A61K6/00
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IT,   LI,   LU,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2006/23]
Extension statesALNot yet paid
HRNot yet paid
LTNot yet paid
LVNot yet paid
MKNot yet paid
TitleGerman:ABGABE VON PHYSIOLOGISCHEN MITTELN MIT IN-SITU GELS MIT ANIONISCHEN POLYSACCHARIDEN[2006/23]
English:DELIVERY OF PHYSIOLOGIXAL AGENTS WITH IN-SITU GELS COMPRISING ANIONIC POLYSACCHARIDES[2006/23]
French:ADMINISTRATION D'AGENTS PHYSIOLOGIQUES AVEC DES GELS IN- SITU COMPRENANT DES POLYSACCHARIDES ANIONIQUES[2006/23]
Entry into regional phase24.03.2006National basic fee paid 
24.03.2006Search fee paid 
24.03.2006Designation fee(s) paid 
24.03.2006Examination fee paid 
Examination procedure24.03.2006Examination requested  [2006/23]
22.05.2006Amendment by applicant (claims and/or description)
14.01.2011Despatch of a communication from the examining division (Time limit: M04)
25.05.2011Application deemed to be withdrawn, date of legal effect  [2011/47]
30.06.2011Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2011/47]
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  14.01.2011
Fees paidRenewal fee
24.03.2006Renewal fee patent year 03
21.05.2007Renewal fee patent year 04
19.06.2008Renewal fee patent year 05
01.10.2010Renewal fee patent year 06
01.10.2010Renewal fee patent year 07
Penalty fee
Additional fee for renewal fee
31.05.200805   M06   Fee paid on   19.06.2008
31.05.201108   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Stay/Interruption02.04.2009Interruption of proceedings. Reason: legal prevention of applicant[2010/30]
01.10.2010Resumption of proceedings[2010/30]
Documents cited:Search[X] US2002119941  (NI YAWEI et al.) [X] 1-84 * the whole document *
 [A] FR2778566  (SEP TARRAL et al.) [A] 1-84 * example 6; claims 1-12 *
 [A] EP1110550  (HOFFMANN LA ROCHE et al.) [A] 1-84 * the whole document *
 [A] WO03043574  (BECTON DICKINSON CO et al.) [A] 1-84 * the whole document *
 [A] WO03020265  (ROCHE VITAMINS AG et al.) [A] 1-84 * the whole document *
 [A] WO9847535  (DANBIOSYST UK et al.) [A] 1-84 * the whole document *
 [AD] US5929051  (NI YAWEI et al.) [AD] 1-84 * examples 13,14; claims 1-78 *
 [L]   R. ROWE ET AL, ED.: "Handbook of pharmaceutical excipients, ed.5", 2007, PHARMACEUTICAL PRESS, XP002544463 [L] 1 * page 507 - page 508 *
 [A]   LINSHU LIU ET AL.: "Pectin-based systems for colon-specific drug delivery via oral route", BIOMATERIALS, vol. 24, 19 August 2003 (2003-08-19), pages 3333 - 3343, XP004425377 [A] 1-84 * the whole document *

DOI:   http://dx.doi.org/10.1016/S0142-9612(03)00213-8
 [A]   P. SRIAMORNSAK: "Effect of calcium concentration, hardening agent and drying condition on release characteristics of oral proteins from calcium pectinate gel beads", EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, vol. 8, 1999, pages 221 - 227, XP002962494 [A] 1-84 * the whole document *

DOI:   http://dx.doi.org/10.1016/S0928-0987(99)00010-X
International search[X] US4978528  (DEGRE FRANCOIS et al.) [X]
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.